Institut Universitaire du Cancer de Toulouse - Oncopole

Toulouse, Haute-Garonne 31059

0 studies enrolling now · 1 studies all time

What they study most

Sickle Cell Disease

Studies at this site

• A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP) — Running, not enrolling